Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Clareo Health | Lymphoma Clinical Trials in Miami | 257 Studies

Clinical Trials LymphomaMiami

Lymphoma Clinical Trials in Miami

Find 257 clinical trials for lymphoma near Miami, Florida. Connect with research centers in your area.

All Lymphoma trials nationwide All trials in Miami

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 181-200 of 257 trials

RecruitingTesting the Combination of Venetoclax and Rituximab, in Comparison to the Usual Treatment (Ibrutinib Plus Rituximab or Zanubrutinib Alone) for Waldenstrom's Macroglobulinemia/Lymphoplasmacytic LymphomaThis phase II trial studies the effects of venetoclax and rituximab in comparison to ibrutinib and rituximab or zanubrutinib in treating patients with previously untreated…NCT04840602·Tucson, Arizona and 144 others

Lymphoma Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

TerminatedSafety and Efficacy Study of Loncastuximab Tesirine + Ibrutinib in Diffuse Large B-Cell or Mantle Cell LymphomaThe purpose of this Phase 1/2 study is to evaluate the safety and efficacy of Loncastuximab Tesirine (ADCT-402) in combination with Ibrutinib in participants with Advanced Diffuse…NCT03684694·Orange, California and 34 others

Active not recruitingSelpercatinib for the Treatment of Advanced Solid Tumors, Lymphomas, or Histiocytic Disorders With Activating RET Gene Alterations, a Pediatric MATCH Treatment TrialThis phase II pediatric MATCH treatment trial studies how well selpercatinib works in treating patients with solid tumors that may have spread from where they first started to…NCT04320888·Birmingham, Alabama and 173 others

CompletedA Study of Revlimid in the Treatment of Non-Hodgkin's LymphomaSubjects who qualify will receive oral lenalidomide daily on days 1-21 of every 28 day cycle.NCT00413036·Muscle Shoals, Alabama and 52 others

RecruitingAZD3470 as Monotherapy or in Combination With Anticancer Agent(s) in Participants With Haematologic Malignancies.This study is designed to evaluate the safety, tolerability, PK, pharmacodynamics, and preliminary efficacy following oral administration of AZD3470 as a monotherapy, and in…NCT06137144·Duarte, California and 38 others

CompletedComparison of Nutritional Supplements in Preventing Weight Loss in Patients With CancerRATIONALE: Nutritional supplements may help prevent loss of appetite, weight loss, and fatigue in patients with advanced cancer.NCT00053053·Birmingham, Alabama and 249 others

CompletedStudy of Oral LBH589 in Adult Patients With Refractory Cutaneous T-Cell LymphomaThis study will evaluate the safety and efficacy of LBH489B in adult patients with refractory Cutaneous T-Cell Lymphoma.NCT00425555·Birmingham, Alabama and 41 others

CompletedSafety, Tolerability and Pharmacokinetics of MRG-106 in Patients With Mycosis Fungoides (MF), CLL, DLBCL or ATLLObjectives of this clinical trial are to evaluate the safety, tolerability, pharmacokinetics and potential efficacy of the investigational drug, cobomarsen (MRG-106), in patients…NCT02580552·Duarte, California and 18 others

RecruitingEpcoritamab in Patients With Newly Diagnosed Marginal Zone Lymphoma (MZL)The purpose of this study is to assess if an investigational treatment of Epcoritamab will be beneficial for patients with Marginal Zone Lymphoma (MZL).NCT06796998·Miami, Florida

Active not recruitingA Study of CD19 Targeted CAR T Cell Therapy in Adult Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukaemia (ALL)This is a Phase 1b/2 study to evaluate the safety and efficacy of autologous T cells engineered with a chimeric antigen receptor (CAR) targeting CD19 in adult patients with…NCT04404660·Duarte, California and 33 others

CompletedLong-Term Followup and/or Thalidomide Maintenance Therapy for Patients Enrolled on Clinical Trial 20030165The study seeks to provide long-term follow-up and/or to offer continued maintenance thalidomide (THALOMID) therapy to those patients enrolled in 20030165.NCT02507336·Miami, Florida

CompletedProleukin in Combination With Rituxan in Patients With Low-Grade Non-Hodgkin's Lymphoma Who Have Previously Failed Rituxan TreatmentsThe purpose of this study is to determine the safety and effectiveness of combination therapy with Proleukin and Rituxan on patients with low-grade Non-Hodgkin's Lymphoma who have…NCT00045877·Little Rock, Arkansas and 64 others

Active not recruitingCombination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic LeukemiaThis randomized phase III trial studies combination chemotherapy with blinatumomab to see how well it works compared to induction chemotherapy alone in treating patients with…NCT02003222·Birmingham, Alabama and 543 others

CompletedA Pivotal Study of Sensory Stimulation in Alzheimer's Disease (HOPE Study)This is a randomized, double-blind, sham-controlled pivotal study of sensory stimulation in subjects with mild to moderate AD.NCT05637801·Gilbert, Arizona and 67 others

CompletedA Brentuximab Vedotin Trial for Patients Who Have Previously Participated in a Brentuximab Vedotin StudyThis is a multicenter, open-label study to evaluate the safety and efficacy of treatment with brentuximab vedotin (SGN-35) in patients who have previously participated in an…NCT00947856·Birmingham, Alabama and 16 others

Active not recruitingIvosidenib in Treating Patients With Advanced Solid Tumors, Lymphoma, or Histiocytic Disorders With IDH1 Mutations (A Pediatric MATCH Treatment Trial)This phase II Pediatric MATCH trial studies how well ivosidenib works in treating patients with solid tumors, including central nervous system tumors, lymphomas and histiocytic…NCT04195555·Birmingham, Alabama and 173 others

RecruitingA Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)This pilot trial assesses the effect of the combination of blinatumomab with dasatinib or imatinib and standard chemotherapy for treating patients with Philadelphia chromosome…NCT06124157·Birmingham, Alabama and 158 others

CompletedComprehensive Oncology Measures for Peripheral T-cell Lymphoma Treatment RegistryProspective, longitudinal, multinational, observational study that will collect data on how patients with peripheral T-cell lymphoma (PTCL) are treated in academic and community…NCT01110733·Tuscaloosa, Alabama and 67 others

CompletedBlood Sample Markers of Reproductive Hormones in Assessing Ovarian Reserve in Younger Patients With Newly Diagnosed LymphomasThis clinical trial studies blood sample markers of reproductive hormones in assessing ovarian reserve in younger patients with newly diagnosed lymphomas.NCT01793233·Birmingham, Alabama and 106 others

RecruitingInotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic LeukemiaThis phase III trial studies the side effects of inotuzumab ozogamicin and how well it works when given with frontline chemotherapy in treating patients with newly diagnosed B…NCT03150693·Birmingham, Alabama and 459 others

PreviousPage 10 of 13Next

Other Conditions in Miami

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia